Time to Adjuvant Therapy and Other Variables in Localized Gastric and Gastroesophageal Junction (GEJ) Cancer (IJGC-D-13-00162)
Shahid Ahmed(Emory University), Kamal Haider(University of Saskatchewan), Nayyer Iqbal(University of Saskatchewan), Adnan Zaidi(University of Saskatchewan), Sunil Kumar Yadav(University of Saskatchewan), D. Nathanael Gardner(University of Saskatchewan), Riaz Alvi(Saskatchewan Cancer Agency), Osama Ahmed(University of Saskatchewan)
Cited by 18
Related Papers
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301
HER2-directed therapy: current treatment options for HER2-positive breast cancer
|Breast Cancer|2015|183
Diabetes and Cancer: Risk, Challenges, Management and Outcomes
|Cancers|2021|183
Current status of immunotherapy in metastatic colorectal cancer
|International Journal of Colorectal Disease|2018|149